ARVO: Latanoprost Halts Myopia Progression in Animal Study
Latanoprost effective for lowering IOP, slowing myopia progression in myopia model
ACP: Recommendations Updated for Low Bone Density Treatment
Osteoporotic women should be treated with pharmacologic therapy for 5 years to cut fracture risk
Activation of Estrogen Receptor α-AF1 May Target Adiposity
ERα-AF1 agonist tamoxifen could reduce food intake and prevent adiposity, insulin resistance, steatosis
Transplanting HCV+ Kidneys Into HCV− Recipients Feasible
Doctors say they can clear hepatitis C in organ recipients, perhaps shortening transplant waits
Hospitals Need to Be Prepared for Ransomware Attacks
Medical information a vulnerable target for those planning ransomware attacks, doctor warns
Leukotriene B4 Is Promising Drug Target for Tx of Lymphedema
Ketoprofen prevents tissue injury, fluid build-up by blocking leukotriene B4, researchers say
ADHD Meds Associated With Reduced Risk for Car Crashes
Symptoms such as inattention, impulsivity raise accident risk, researchers say
Life Expectancy for HIV+ Patients Up Since Introduction of ART
Physicians need to focus on encouraging patients to take their drugs consistently
Postmarket Safety Events for 32 Percent of Novel Therapeutics
Thirty-two percent of 222 FDA approved novel therapeutics from 2001 to 2010 were affected
Vitamin D Doesn’t Impact Insulin Sensitivity, Secretion in T2DM
No difference between or within groups in insulin sensitivity, glycemic control with vitamin D3, placebo
